Status:
RECRUITING
Mechanisms of Exposure Therapy for OCD
Lead Sponsor:
Mclean Hospital
Conditions:
Obsessive-Compulsive Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Exposure therapy is the most effective treatment available for obsessive compulsive disorder, yet up to 50% of patients do not recover because the mechanisms underlying successful response are poorly ...
Eligibility Criteria
Inclusion
- Between the ages of 18-65 years old
- Seeking exposure treatment at McLean Hospital OCD Institute or San Diego State University
- Have a diagnosis of OCD
- Able to complete study measures and treatment procedures in English
Exclusion
- Acute symptoms of psychosis
- Active suicidality (plan, means, intent and/or suicide attempt in past 3 months)
- Presence of co-occurring symptoms that warrant higher level of care (e.g., inpatient treatment)
- Presence of any medical, psychiatric, or developmental condition that would prevent patients from completing assessments or exposure exercises (e.g., non-verbal autism spectrum disorder)
Key Trial Info
Start Date :
October 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2029
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06173752
Start Date
October 16 2024
End Date
April 1 2029
Last Update
January 5 2026
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Understanding and Treating Anxiety
San Diego, California, United States, 92120
2
McLean OCDI
Belmont, Massachusetts, United States, 02478